Leila A. Mankarious, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cricoid Cartilage | 10 | 2010 | 72 | 2.300 |
Why?
|
| Hearing Loss, Sensorineural | 5 | 2022 | 770 | 1.280 |
Why?
|
| Hearing Loss | 4 | 2022 | 765 | 1.100 |
Why?
|
| Deafness | 2 | 2022 | 461 | 0.890 |
Why?
|
| Hearing Loss, Unilateral | 1 | 2022 | 26 | 0.820 |
Why?
|
| Thyroglossal Cyst | 2 | 2011 | 31 | 0.730 |
Why?
|
| Transforming Growth Factor beta3 | 2 | 2008 | 44 | 0.650 |
Why?
|
| Language Development Disorders | 1 | 2020 | 196 | 0.640 |
Why?
|
| Cochlear Implantation | 4 | 2022 | 310 | 0.640 |
Why?
|
| Motor Skills | 1 | 2020 | 518 | 0.580 |
Why?
|
| Cytomegalovirus Infections | 1 | 2022 | 817 | 0.520 |
Why?
|
| Chondrocytes | 6 | 2008 | 803 | 0.510 |
Why?
|
| Glottis | 3 | 2006 | 217 | 0.480 |
Why?
|
| Salivary Glands | 2 | 2011 | 228 | 0.420 |
Why?
|
| POU Domain Factors | 1 | 2010 | 46 | 0.380 |
Why?
|
| Hearing | 3 | 2022 | 479 | 0.380 |
Why?
|
| Maxillofacial Development | 1 | 2010 | 88 | 0.370 |
Why?
|
| Respiratory System | 2 | 2010 | 555 | 0.360 |
Why?
|
| Extracellular Matrix Proteins | 3 | 2003 | 849 | 0.350 |
Why?
|
| Laryngitis | 1 | 2009 | 27 | 0.340 |
Why?
|
| Larynx | 2 | 2010 | 492 | 0.300 |
Why?
|
| Immunoglobulin A | 1 | 2011 | 992 | 0.300 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2010 | 370 | 0.290 |
Why?
|
| Saliva | 1 | 2011 | 805 | 0.280 |
Why?
|
| Connective Tissue | 1 | 2008 | 420 | 0.280 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2008 | 472 | 0.280 |
Why?
|
| Skull | 1 | 2010 | 810 | 0.270 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2008 | 638 | 0.260 |
Why?
|
| Collagen Type II | 2 | 2003 | 151 | 0.260 |
Why?
|
| Drainage | 1 | 2011 | 1140 | 0.260 |
Why?
|
| Immunohistochemistry | 9 | 2011 | 11363 | 0.240 |
Why?
|
| Registries | 1 | 2020 | 8077 | 0.240 |
Why?
|
| Otoscopy | 2 | 2021 | 36 | 0.240 |
Why?
|
| Child, Preschool | 17 | 2022 | 40955 | 0.230 |
Why?
|
| Epithelium | 1 | 2008 | 1680 | 0.220 |
Why?
|
| Electronic Health Records | 1 | 2020 | 4440 | 0.220 |
Why?
|
| Cognition | 1 | 2020 | 6722 | 0.210 |
Why?
|
| Proteoglycans | 2 | 2003 | 834 | 0.210 |
Why?
|
| Aggrecans | 3 | 2010 | 90 | 0.200 |
Why?
|
| Vestibular Aqueduct | 1 | 2021 | 66 | 0.190 |
Why?
|
| Cartilage | 2 | 2002 | 818 | 0.190 |
Why?
|
| Tracheal Stenosis | 1 | 2002 | 226 | 0.180 |
Why?
|
| Audiometry, Pure-Tone | 1 | 2020 | 204 | 0.170 |
Why?
|
| Sialorrhea | 1 | 1999 | 25 | 0.170 |
Why?
|
| Cochlear Implants | 2 | 2022 | 339 | 0.170 |
Why?
|
| Respiration Disorders | 1 | 2002 | 370 | 0.170 |
Why?
|
| Otitis Media | 1 | 2021 | 277 | 0.170 |
Why?
|
| Ibuprofen | 1 | 2021 | 235 | 0.170 |
Why?
|
| Otologic Surgical Procedures | 1 | 2020 | 145 | 0.170 |
Why?
|
| Submandibular Gland | 1 | 1999 | 86 | 0.170 |
Why?
|
| Collagen Type I | 1 | 2002 | 592 | 0.170 |
Why?
|
| Ear Diseases | 1 | 2020 | 169 | 0.160 |
Why?
|
| Animals, Newborn | 3 | 2010 | 2723 | 0.160 |
Why?
|
| Wound Healing | 3 | 2009 | 2781 | 0.160 |
Why?
|
| Tonsillectomy | 1 | 2021 | 254 | 0.160 |
Why?
|
| Speech Perception | 1 | 2022 | 489 | 0.150 |
Why?
|
| Dermoid Cyst | 1 | 1998 | 92 | 0.150 |
Why?
|
| Intubation, Intratracheal | 2 | 2003 | 1357 | 0.150 |
Why?
|
| Aging | 2 | 2009 | 8626 | 0.150 |
Why?
|
| Automation | 1 | 2020 | 584 | 0.150 |
Why?
|
| Child | 16 | 2022 | 77478 | 0.150 |
Why?
|
| Nose Neoplasms | 1 | 1998 | 245 | 0.140 |
Why?
|
| Organ Culture Techniques | 2 | 2010 | 808 | 0.130 |
Why?
|
| Pilot Projects | 5 | 2021 | 8297 | 0.130 |
Why?
|
| Auditory Perception | 1 | 2020 | 568 | 0.130 |
Why?
|
| Ear, External | 1 | 1996 | 160 | 0.130 |
Why?
|
| Replantation | 1 | 1996 | 148 | 0.130 |
Why?
|
| Intelligence | 1 | 2020 | 920 | 0.130 |
Why?
|
| Laryngeal Mucosa | 2 | 2006 | 31 | 0.130 |
Why?
|
| Amputation, Traumatic | 1 | 1996 | 123 | 0.130 |
Why?
|
| Rhinoplasty | 1 | 1998 | 226 | 0.130 |
Why?
|
| Postoperative Period | 2 | 2011 | 1839 | 0.120 |
Why?
|
| Disease Transmission, Infectious | 1 | 2020 | 546 | 0.120 |
Why?
|
| Rabbits | 3 | 2009 | 4886 | 0.120 |
Why?
|
| Physical Examination | 1 | 2020 | 1239 | 0.120 |
Why?
|
| Cytokines | 1 | 2009 | 7317 | 0.120 |
Why?
|
| Pain, Postoperative | 2 | 2021 | 1638 | 0.120 |
Why?
|
| Analgesics | 1 | 2020 | 1037 | 0.120 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2008 | 643 | 0.120 |
Why?
|
| Telemedicine | 2 | 2021 | 2853 | 0.120 |
Why?
|
| Apoptosis | 3 | 2010 | 9715 | 0.110 |
Why?
|
| Cochlea | 1 | 2019 | 828 | 0.110 |
Why?
|
| Infant | 10 | 2021 | 35070 | 0.110 |
Why?
|
| Temporal Bone | 2 | 2018 | 661 | 0.100 |
Why?
|
| Retrospective Studies | 9 | 2022 | 77098 | 0.100 |
Why?
|
| Proliferating Cell Nuclear Antigen | 2 | 2003 | 283 | 0.100 |
Why?
|
| Endoscopy | 1 | 2020 | 1774 | 0.090 |
Why?
|
| Microsurgery | 1 | 1996 | 796 | 0.090 |
Why?
|
| Audiometry | 1 | 2010 | 242 | 0.090 |
Why?
|
| Hearing Tests | 2 | 2022 | 122 | 0.090 |
Why?
|
| Adolescent | 13 | 2021 | 85649 | 0.090 |
Why?
|
| Lectins, C-Type | 2 | 2003 | 588 | 0.090 |
Why?
|
| alpha-Amylases | 1 | 2009 | 41 | 0.090 |
Why?
|
| Hyoid Bone | 1 | 2009 | 38 | 0.090 |
Why?
|
| Salivary Proteins and Peptides | 1 | 2009 | 52 | 0.080 |
Why?
|
| Mucin 5AC | 1 | 2009 | 93 | 0.080 |
Why?
|
| Respiratory System Abnormalities | 1 | 2009 | 69 | 0.080 |
Why?
|
| Humans | 27 | 2022 | 742088 | 0.080 |
Why?
|
| Dipeptides | 1 | 2010 | 409 | 0.080 |
Why?
|
| Smad2 Protein | 1 | 2008 | 156 | 0.080 |
Why?
|
| Matrix Metalloproteinases | 1 | 2010 | 391 | 0.080 |
Why?
|
| Ear, Inner | 1 | 2011 | 420 | 0.070 |
Why?
|
| Elastic Tissue | 1 | 2006 | 65 | 0.070 |
Why?
|
| Cell Count | 2 | 2000 | 1831 | 0.070 |
Why?
|
| Mutation | 1 | 2010 | 29717 | 0.070 |
Why?
|
| Protease Inhibitors | 1 | 2010 | 790 | 0.070 |
Why?
|
| Mucins | 1 | 2009 | 564 | 0.070 |
Why?
|
| Software | 1 | 2020 | 4434 | 0.070 |
Why?
|
| Follow-Up Studies | 4 | 2011 | 39004 | 0.060 |
Why?
|
| Animals | 9 | 2010 | 168561 | 0.060 |
Why?
|
| Cell Division | 2 | 2003 | 4564 | 0.060 |
Why?
|
| Respiratory Tract Diseases | 1 | 2009 | 722 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 3862 | 0.060 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2003 | 130 | 0.060 |
Why?
|
| Orbital Pseudotumor | 1 | 2003 | 42 | 0.060 |
Why?
|
| Bionics | 1 | 2022 | 42 | 0.050 |
Why?
|
| Fetus | 2 | 2000 | 1879 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3130 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3236 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 1 | 2009 | 2699 | 0.050 |
Why?
|
| Mice | 4 | 2010 | 81045 | 0.050 |
Why?
|
| Otitis | 1 | 2000 | 20 | 0.050 |
Why?
|
| Tympanic Membrane Perforation | 1 | 2020 | 41 | 0.050 |
Why?
|
| Cholesteatoma, Middle Ear | 1 | 2020 | 49 | 0.050 |
Why?
|
| Trauma Severity Indices | 1 | 2002 | 481 | 0.050 |
Why?
|
| DNA Fragmentation | 1 | 2000 | 242 | 0.050 |
Why?
|
| Tympanic Membrane | 1 | 2021 | 224 | 0.040 |
Why?
|
| Methicillin Resistance | 1 | 2000 | 198 | 0.040 |
Why?
|
| Adenoidectomy | 1 | 2021 | 159 | 0.040 |
Why?
|
| Laryngostenosis | 1 | 2000 | 161 | 0.040 |
Why?
|
| Respiratory Sounds | 1 | 2002 | 693 | 0.040 |
Why?
|
| Age Factors | 3 | 2011 | 18355 | 0.040 |
Why?
|
| Postoperative Hemorrhage | 1 | 2021 | 409 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2009 | 18006 | 0.040 |
Why?
|
| Esthetics | 1 | 1998 | 306 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2008 | 8436 | 0.040 |
Why?
|
| Infant, Newborn | 4 | 2021 | 25575 | 0.040 |
Why?
|
| Leeches | 1 | 1996 | 11 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2000 | 2505 | 0.030 |
Why?
|
| Neuromuscular Diseases | 1 | 1999 | 253 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2000 | 1969 | 0.030 |
Why?
|
| Pediatrics | 1 | 2009 | 3462 | 0.030 |
Why?
|
| Biomedical Research | 1 | 2009 | 3306 | 0.030 |
Why?
|
| Reproducibility of Results | 3 | 2021 | 19862 | 0.030 |
Why?
|
| Regeneration | 1 | 2002 | 1485 | 0.030 |
Why?
|
| Male | 10 | 2020 | 349538 | 0.030 |
Why?
|
| Reoperation | 1 | 2022 | 4200 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2000 | 1740 | 0.030 |
Why?
|
| Glycoproteins | 1 | 2000 | 2260 | 0.030 |
Why?
|
| Staphylococcus aureus | 1 | 2000 | 1449 | 0.030 |
Why?
|
| Quality of Life | 1 | 2013 | 12730 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2008 | 10472 | 0.030 |
Why?
|
| Gestational Age | 1 | 2000 | 3490 | 0.030 |
Why?
|
| Collagen | 1 | 2000 | 2684 | 0.030 |
Why?
|
| Treatment Outcome | 4 | 2020 | 62966 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2020 | 3418 | 0.020 |
Why?
|
| Pandemics | 2 | 2021 | 8328 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2000 | 6483 | 0.020 |
Why?
|
| Female | 9 | 2020 | 379592 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2011 | 20086 | 0.020 |
Why?
|
| Head and Neck Neoplasms | 1 | 2003 | 2712 | 0.020 |
Why?
|
| Postoperative Care | 1 | 1996 | 1484 | 0.020 |
Why?
|
| Time Factors | 2 | 2020 | 40054 | 0.020 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2009 | 780 | 0.020 |
Why?
|
| Comorbidity | 1 | 2020 | 10372 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2021 | 13921 | 0.020 |
Why?
|
| Graft Survival | 1 | 1996 | 3733 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2018 | 3439 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 1999 | 15056 | 0.010 |
Why?
|
| Models, Animal | 1 | 2009 | 2170 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2000 | 9274 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2000 | 7153 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 1999 | 15530 | 0.010 |
Why?
|
| Mastoiditis | 1 | 2000 | 34 | 0.010 |
Why?
|
| Anticoagulants | 1 | 1996 | 4595 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2020 | 40450 | 0.010 |
Why?
|
| Community-Acquired Infections | 1 | 2000 | 463 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 1999 | 15244 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2000 | 2271 | 0.010 |
Why?
|
| Adult | 2 | 2002 | 213712 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 2009 | 3507 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2011 | 21719 | 0.010 |
Why?
|
| Risk Factors | 1 | 1999 | 72145 | 0.010 |
Why?
|
| Middle Aged | 1 | 2002 | 213127 | 0.000 |
Why?
|
| United States | 1 | 2009 | 69693 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2003 | 35342 | 0.000 |
Why?
|